DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+19.07%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.81B
AUM Growth
-$7.23M
(-0.26%)
Cap. Flow
-$616M
Cap. Flow
% of AUM
-21.93%
Top 10 Holdings %
Top 10 Hldgs %
28.25%
Holding
132
New
16
Increased
23
Reduced
29
Closed
15
Top Buys
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$54.6M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$54.4M |
| 3 |
Tandem Diabetes Care
TNDM
|
$49.7M |
| 4 |
Xeris Biopharma Holdings
XERS
|
$47.4M |
| 5 |
Sarepta Therapeutics
SRPT
|
$39.1M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$93.4M |
| 2 |
DexCom
DXCM
|
$46M |
| 3 |
Natera
NTRA
|
$39.5M |
| 4 |
Glaukos
GKOS
|
$36.1M |
| 5 |
Centene
CNC
|
$32.5M |
Sector Composition
| 1 | Healthcare | 74.9% |
| 2 | Financials | 2.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
26
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $32.5M | 1.14% |
233,000
+7,548
| +3% | +$1.05M |
|
27
Ascendis Pharma
ASND
$12.1B
| $32.1M | 1.13% |
482,467
| – | – |
|
|
ECYT
28
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $32.1M | 1.13% |
2,324,299
-303,241
| -12% | -$4.18M |
|
|
WBA
29
DELISTED
Walgreens Boots Alliance
WBA
| $31.9M | 1.12% |
531,000
+175,000
| +49% | +$10.5M |
|
|
30
Glaukos
GKOS
$5.23B
| $30.7M | 1.08% |
754,222
-888,809
| -54% | -$36.1M |
|
31
Acadia Healthcare
ACHC
$2.16B
| $30.3M | 1.06% |
741,016
| – | – |
|
|
BPMC
32
DELISTED
Blueprint Medicines
BPMC
| $30.2M | 1.06% |
474,950
+96,000
| +25% | +$6.09M |
|
33
Agios Pharmaceuticals
AGIO
$2.1B
| $29.5M | 1.04% |
350,000
-16,000
| -4% | -$1.35M |
|
34
Universal Health Services
UHS
$11.7B
| $29.2M | 1.03% |
262,000
| – | – |
|
|
IMMU
35
DELISTED
Immunomedics Inc
IMMU
| $26.6M | 0.94% |
1,124,800
+194,352
| +21% | +$4.6M |
|
|
DFBHU
36
DELISTED
DFB Healthcare Acquisitions Corp. Unit
DFBHU
| $25.4M | 0.89% |
2,500,000
| – | – |
|
|
MLNT
37
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $25.4M | 0.89% |
799,161
+173,592
| +28% | +$5.51M |
|
|
LCI
38
DELISTED
Lannett Company, Inc.
LCI
| $24.5M | 0.86% |
450,338
-234,931
| -34% | -$12.8M |
|
39
eHealth
EHTH
$121M
| $24.4M | 0.86% |
1,104,952
+74,150
| +7% | +$1.64M |
|
|
EPZM
40
DELISTED
Epizyme, Inc
EPZM
| $22.2M | 0.78% |
1,639,000
+678,030
| +71% | +$9.19M |
|
41
Rhythm Pharmaceuticals
RYTM
$6.88B
| $22M | 0.77% |
703,600
+121,590
| +21% | +$3.8M |
|
|
RETA
42
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $21.3M | 0.75% |
609,554
+219,554
| +56% | +$7.68M |
|
43
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $21.3M | 0.75% |
+1,226,890
| New | +$21.3M |
|
44
Brookdale Senior Living
BKD
$1.8B
| $21M | 0.74% |
+2,305,773
| New | +$21M |
|
|
45
Natera
NTRA
$23B
| $20.3M | 0.71% |
1,080,829
-2,099,171
| -66% | -$39.5M |
|
|
MOR
46
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $18.2M | 0.64% |
+600,000
| New | +$18.2M |
|
|
AIMT
47
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $18.1M | 0.64% |
673,000
-37,210
| -5% | -$1M |
|
|
CBAY
48
DELISTED
Cymabay Therapeutics
CBAY
| $18M | 0.63% |
1,343,181
+130,000
| +11% | +$1.74M |
|
|
BLUE
49
DELISTED
bluebird bio
BLUE
| $17.7M | 0.62% |
8,724
+5,559
| +176% | +$11.3M |
|
|
AAC
50
DELISTED
AAC Holdings, Inc.
AAC
| $17.4M | 0.61% |
1,853,998
| – | – |
|